The UK's Office for Statistics Regulation (OSR) reported on July 22, 2026, that NHS England will amend its official statements regarding the effectiveness of Palantir's Federated Data Platform (FDP). This action follows an investigation into claims that the software helped perform an additional 110,000 surgeries and cut discharge delays by 15%.
NHS England will now include a disclaimer clarifying that current data does not substantiate these specific figures as direct causal results, noting that other variables were not accounted for. The modification emphasizes the need for transparency in public health data, particularly concerning the significant £330 million contract awarded to Palantir for the FDP. No market reaction was mentioned in the reports.